Saudi Arabia well positioned to ride medical tourism wave

While the broader tourism industry generally receives extensive scholarly and public attention for its economic contributions and cultural exchanges, much less focus is placed on one of its most significant and rapidly evolving segments: medical tourism. This specialized form of travel is poised to become a trillion-dollar global industry.

This is being fueled by escalating healthcare costs in developed nations, technological advancements and the desire for timely and high-quality care. This is why medical tourism represents an intriguing intersection of health and tourism that offers substantial untapped potential.

The Middle East is exceptionally well positioned to emerge as a premier destination in this space by leveraging its world-class infrastructure, strategic geographic location and cultural resonance. For example, Saudi Arabia’s transformative Vision 2030 initiative aims to attract international patients who are seeking affordability combined with unparalleled hospitality and recovery environments.

Patients from the US, Canada and Western Europe frequently face prohibitive expenses or long wait times

Dr. Majid Rafizadeh

Recent market analyses project robust expansion for medical tourism. Estimates for the global market size vary but consistently indicate values in the tens to low hundreds of billions of dollars, with upper forecasts exceeding $126 billion by 2035, driven by compound annual growth rates often exceeding 14 percent.

Some projections envision broader health-related travel contributing toward trillion-dollar scales when including wellness and ancillary tourism spending.

Key drivers include cost. For example, patients from the US, Canada and Western Europe frequently face prohibitive expenses or long wait times for elective procedures. Heart bypass surgery, for instance, can cost $200,000 in the US, but it is significantly less expensive in other countries. Orthopedic procedures, such as hip replacements, similarly offer savings of more than 50 percent.

Other motivators include access to specialized or unavailable treatments, shorter wait times, high-quality care and the appeal of combining medical care with tourism and recovery in attractive locations.

The most common procedures involved in medical tourism span several categories. For example, cosmetic surgeries — including abdominoplasty, breast augmentation, liposuction and hair transplants — remain highly popular due to their elective nature and substantial cost savings. Other areas that dominate include dental care, orthopedics (including joint replacements and spinal surgery), cardiovascular interventions, weight-loss surgery, fertility procedures and cataract surgery.

Top source countries include the US, UK, Canada and, increasingly, China and Russia.

This trend is reshaping other sectors as well. Medical tourism can stimulate the economy, increase investment in destination countries and generate revenue. Medical travelers contribute higher per capita spending than leisure tourists, boosting hospitality, transport and other related services.

The Middle East possesses unique strengths for expansion in this area, including its strategic geography bridging Europe, Asia and Africa, substantial capital for infrastructure, and growing emphasis on economic diversification.

The Gulf Cooperation Council medical tourism market alone was valued at $9.6 billion in 2025, with a projection of $22.5 billion by 2034. Countries like Saudi Arabia and the UAE have pioneered luxury healthcare in state-of-the-art facilities, while Jordan and others focus on specific niches.

Saudi Arabia stands out due to its ambitious Vision 2030 framework, which explicitly targets healthcare transformation and tourism diversification as pillars of its economic resilience beyond oil. The Kingdom is investing heavily in modern hospitals, specialized centers and public-private partnerships to elevate service quality and capacity.

For example, initiatives under the Health Sector Transformation Program aim to privatize segments, attract foreign investment and position Saudi Arabia as a regional and global health hub.

Countries like Saudi Arabia and the UAE have pioneered luxury healthcare in state-of-the-art facilities

Dr. Majid Rafizadeh

Some of the key strengths of the Kingdom include advanced infrastructure in major cities like Riyadh and Jeddah, world-class expertise in areas such as cardiology, oncology, orthopedics and wellness, and cultural/religious appeal for many patients.

Its competitiveness is also being enhanced by government-backed marketing, eased visa processes for medical travelers and the sector’s integration with hospitality, such as luxury resorts for recovery. Saudi Arabia’s medical tourism market is projected to more than triple by 2030, growing from $200 million in 2024 to about $680 million.

Saudi Arabia can target high-value segments like complex surgeries, regenerative medicine and medical wellness retreats.

There will be challenges for other Middle Eastern countries, including in easing potential shortages in specialized personnel, ensuring consistent quality across facilities and enhancing infrastructure.

To capitalize fully, the Middle East should prioritize five actions: aggressive international marketing campaigns highlighting cost-effectiveness and unique cultural offerings; expanded incentives for foreign direct investments; workforce development through training and international recruitment; medical visas integrated with tourism packages; and leveraging technologies like artificial intelligence diagnostics and smart hospitals to demonstrate innovation.

In summary, medical tourism remains underappreciated. It is a transformative component of tourism with the potential to reach trillion-dollar scales through integrated healthcare and wellness travel. Saudi Arabia stands out as an ideal destination due to the fact it can leverage its advanced medical infrastructure, visionary policies under Vision 2030, strategic location and rich cultural offerings to attract a growing number of international patients.

• Dr. Majid Rafizadeh is a Harvard-educated Iranian-American political scientist. X: @Dr_Rafizadeh